The role of latanoprost in an inflammatory bowel disease flare.

Autor:	Paul S; Department of Gastroenterology and Hepatology, Tufts Medical Center, Boston, MA, USA, Department of Ophthalmology, University of Connecticut School of Medicine and Consulting Ophthalmologists, Farmington, CT, USA and Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA spaul1@tuftsmedicalcenter.org., Wand M; Department of Gastroenterology and Hepatology, Tufts Medical Center, Boston, MA, USA, Department of Ophthalmology, University of Connecticut School of Medicine and Consulting Ophthalmologists, Farmington, CT, USA and Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA., Emerick GT; Department of Gastroenterology and Hepatology, Tufts Medical Center, Boston, MA, USA, Department of Ophthalmology, University of Connecticut School of Medicine and Consulting Ophthalmologists, Farmington, CT, USA and Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA., Richter JM; Department of Gastroenterology and Hepatology, Tufts Medical Center, Boston, MA, USA, Department of Ophthalmology, University of Connecticut School of Medicine and Consulting Ophthalmologists, Farmington, CT, USA and Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
Jazyk:	angličtina
Zdroj:	Gastroenterology report [Gastroenterol Rep (Oxf)] 2014 Aug; Vol. 2 (3), pp. 232-4. Date of Electronic Publication: 2014 Jul 26.
DOI:	10.1093/gastro/gou044
Abstrakt:	Ulcerative colitis and Crohn's disease (CD) are characterized by inflammation of the intestinal mucosa and symptoms of abdominal pain and diarrhea. Many studies have shown an association between elevated levels of prostaglandins and mucosal damage in inflammatory bowel disease. We report a 50-year-old woman with a history of CD and open-angle glaucoma. Her glaucoma was treated with latanoprost, a prostaglandin analog, which was associated with an exacerbation of her CD. On discontinuation of latanoprost, her CD symptoms disappeared completely. This case suggests that in a patient with CD, topical administration of latanoprost may result in sufficient systemic absorption and circulation to promote a relapse of CD. This finding has important implications, not only for patients with inflammatory bowel disease and glaucoma, but also for both ophthalmologists and gastroenterologists. (© The Author(s) 2014. Published by Oxford University Press and the Digestive Science Publishing Co. Limited.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu